Nesvacumab (ANGPT2) - Research Grade Biosimilar
Product Specifications
Background
Nesvacumab is under investigation in clinical trial NCT01997164, Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (Wet) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) .
Immunogen
Homo sapiens / ANGPT2 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-nd
NCBI Organism
Homo sapiens
Other Product Names
REGN-910
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
